Softgel capsules are gelatin-based shells filled with liquid, paste, or suspension formulations. These capsules provide several advantages, including precise dosing, improved patient compliance, and protection of sensitive ingredients from environmental factors such as oxygen and moisture. Their versatility makes them highly suitable for encapsulating oils, fat-soluble vitamins, and poorly soluble drugs. The market is expanding due to the growing prevalence of chronic diseases, increasing health awareness, and rising adoption of nutraceutical products. Additionally, innovations in encapsulation technologies and the development of vegetarian softgel alternatives are creating new growth opportunities.
The global Softgel Capsules Market share in 2026 is witnessing steady growth, driven by increasing demand for advanced drug delivery systems and rising consumer preference for easy-to-swallow dosage forms. Softgel capsules are widely used across pharmaceutical, nutraceutical, and cosmetic industries due to their enhanced bioavailability, improved stability, and ability to encapsulate liquid or semi-solid formulations.
According to Fortune Business Insights, the global softgel capsules market size was valued at USD 7.87 billion in 2025. The market is projected to grow from USD 8.32 billion in 2026 to USD 13.46 billion by 2034, exhibiting a CAGR of 6.20% during the forecast period. North America dominated the market with a share of 35.58% in 2025, owing to strong pharmaceutical infrastructure and increasing dietary supplement consumption.
Top Companies In The Market
- Lonza (Switzerland)
- Sirio Pharma (China)
- Catalent Inc. (U.S.)
- Hunan Er Kang Pharmaceutical Co., Ltd (China)
- Aenova Group GmbH (Germany)
- Fuji Capsule Co., Ltd. (Japan)
- Captek Softgel International Inc. (U.S.)
- Curtis Health Caps S.A. (Poland)
- EuroCaps Ltd (U.K.)
- ALCALÁ FARMA laboratories (SYNERLAB) (Spain)
- Cloverty (Spain)
Market Drivers & Restraints:
Drivers: The increasing demand for nutraceuticals and dietary supplements is a major driver of the softgel capsules market. Consumers are becoming more health-conscious and prefer convenient dosage forms such as softgels. Furthermore, the pharmaceutical industry is increasingly utilizing softgel technology to enhance drug solubility and bioavailability, particularly for poorly water-soluble drugs.
Technological advancements in encapsulation processes, including innovative sealing techniques and plant-based capsule development, are further boosting market growth. The rising aging population and growing incidence of chronic diseases such as cardiovascular disorders and arthritis are also contributing to increased demand.
Restraints: Despite strong growth prospects, the market faces challenges such as high production costs and stringent regulatory requirements. The use of gelatin derived from animal sources raises concerns among vegetarian and vegan consumers, which may limit market expansion in certain regions. Additionally, maintaining product stability during storage and transportation can be complex.
Market Report Coverage:
The report provides a comprehensive analysis of the softgel capsules market, covering key aspects such as market size, growth trends, and competitive dynamics. It includes detailed insights into market drivers, restraints, opportunities, and challenges. The report also highlights technological advancements, regulatory frameworks, and emerging trends shaping the industry.
Furthermore, it offers in-depth segmentation analysis and regional outlook, enabling stakeholders to identify growth opportunities and make informed business decisions. The competitive landscape section provides detailed profiles of key market players, including their strategies, product offerings, and recent developments.
Market Competitive Landscape:
The softgel capsules market is highly competitive, with several global and regional players focusing on product innovation, strategic partnerships, and capacity expansion. Leading companies are investing in research and development to introduce advanced formulations and expand their product portfolios.
Collaborations and mergers are common strategies adopted by market players to strengthen their market presence. Companies are also focusing on expanding their manufacturing capabilities to meet the growing demand from pharmaceutical and nutraceutical sectors.
Market Segments:
The softgel capsules market can be segmented based
By Type (Gelatin Capsules and Non Animal Softgel Capsules {Starches, Pullulan, and Others})
By Application (Prescription Medicines, OTC, and Nutraceutical)
By Manufacturers (Pharmaceutical Companies, Nutraceutical Companies, and Others)
Explore the full research report with detailed insights and TOC: https://www.fortunebusinessinsights.com/softgel-capsules-market-103353
Market Regional Insights:
North America: North America dominates the softgel capsules market, driven by advanced healthcare infrastructure, high adoption of dietary supplements, and strong presence of key market players.
Europe: Europe holds a significant share, supported by increasing demand for nutraceutical products and growing awareness about preventive healthcare.
Asia Pacific: The Asia Pacific region is expected to witness the fastest growth, owing to rising healthcare expenditure, expanding pharmaceutical industry, and increasing consumer awareness.
Latin America and Middle East & Africa: These regions are experiencing gradual growth due to improving healthcare infrastructure and increasing demand for pharmaceutical products.
Future Market Scope:
The future of the softgel capsules market looks promising, with continuous advancements in encapsulation technologies and growing demand for innovative drug delivery systems. The development of plant-based softgel capsules is expected to gain traction, catering to the rising demand for vegan and vegetarian products.
Additionally, increasing investments in research and development, coupled with expanding applications in cosmetics and functional foods, will further drive market growth. The integration of advanced manufacturing technologies and automation is also expected to enhance production efficiency and reduce costs.
Overall, the softgel capsules market is poised for steady expansion, supported by strong demand across multiple industries and ongoing technological advancements.
Recent Industry Development
February 2025: Jupiter Neurosciences Inc., a pharmaceutical company developing JOTROL, collaborated with Catalent Pharma Solutions LLC for the production of JOTROL softgel capsules to support Jupiter’s upcoming Phase 2a clinical trial in Parkinson’s disease. Under the collaboration, Catalent manufactured clinical batches of JOTROL, using an optimized softgel formulation.
Contact us:
Fortune Business Insights™ Pvt.
Phone: USA: +1 833 909 2966 (Toll-Free),
United Kingdom: +44 808 502 0280 (Toll-Free),
APAC: +91 744 740 1245
Email: [email protected]